# $urgn

Urogen Pharma (URGN) is mentioned in analyst upgrades for a related company, while also being noted as underperforming among commercialization-stage biotechs. An expert highlights URGN as a past success with potential for future gains.

### About $urgn
Urogen Pharma Ltd. is a biopharmaceutical company focused on developing and commercializing novel solutions for urological diseases.  

### Top $urgn Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Raymond James $TYRA's PT to $55 from $35 and reiterated at Strong Buy. $URGN $JNJ PFE MRK ALPMY Raymond James said in its note: Remain Strong Buy rated on TYRA shares and raise our price target to $55 after layering estimates for dabogratinib in upper tract urothelial carcinoma (UTUC) into our model. Recall that although this is a smaller opportunity (around 3K U.S. patients) TYRA can accelerate the development here (a Phase [--] trial has recently been initiated) with the potential for this to be the first approved indication for dabogratinib (which we estimate in early [----] a couple of"  
[X Link](https://x.com/Quantumup1/status/2016625267691683922) [@Quantumup1](/creator/x/Quantumup1) 2026-01-28T21:31Z [----] followers, [----] engagements


"Ready for the moon ride $BMRN $ALEC $ALLO $SUPN $TRVI $BIIB $ARVN $ZURA $NVAX $JAZZ $SBTX $IDYA $INCY $EXEL $CMRX $ALKS $NAMS $ABCL $DAWN $ICPT $IRTC $ACHL $PTGX $KRYS $TGTX $PRVB $ENta $RXRX $AMRN $IRWD $URGN $RPTX $SAGE $ARWR $VACC $TWST $FOLD $MRTX $AUAU.V $AUXXF $AUAU A2Gold Expands Eastside Drilling To 30000m 🚨 A2 Gold announced it just kicked off a fully funded year-long drill program at its district-scale Eastside Gold-Silver Project in Nevada which is a major step up from the original 18000m plan. 🔸 https://t.co/YKsRREUdvS $AUAU.V $AUXXF $AUAU A2Gold Expands Eastside Drilling To"  
[X Link](https://x.com/mariostario2019/status/2016197008395030959) [@mariostario2019](/creator/x/mariostario2019) 2026-01-27T17:10Z [--] followers, [---] engagements


"Most of the Commercialization-stage bios that I follow (and generally like) are down YTD and down significantly from their 52-week highs despite biotech indices being up YTD and after a strong Q425. $ABEO $BCRX $CRMD $EOLS $ETON $HRMY $HROW $IOVA $OCUL $RIGL $SLNO $TARS $URGN"  
[X Link](https://x.com/DeepSouthDoctor/status/2015204062531088860) [@DeepSouthDoctor](/creator/x/DeepSouthDoctor) 2026-01-24T23:24Z [----] followers, [----] engagements


"If you followed me last year you know we hit a few biotech home runs like Lineage Cell Therapeutics ( $LCTX) UroGen Pharma ( $URGN) Avidity Biosciences ( $RNA) Teva Pharmaceutical Industries ( $TEVA) and more. That was thanks to our biotech expert who previously managed a $1B hedge fund and now shares his best ideas with us as a way of giving back to the community. Today were introducing what we believe could be the first home run of [----]. Massive CEO buying a near-perfect setup and multiple asymmetric catalysts ahead. Ill publish the full conversation later today. Hope it helps everyone."  
[X Link](https://x.com/ZeeContrarian1/status/2009228848341365035) [@ZeeContrarian1](/creator/x/ZeeContrarian1) 2026-01-08T11:41Z 36.8K followers, 106.1K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing